Onto Innovation [ONTO] vs Nova [NVMI] Detailed Stock Comparison
Onto Innovation
NYSE
Loading...
Nova
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Onto Innovation wins in 8 metrics, Nova wins in 11 metrics, with 0 ties. Nova appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Onto Innovation | Nova | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.99 | 41.14 | Onto Innovation |
| Price-to-Book Ratio | 2.47 | 8.13 | Onto Innovation |
| Debt-to-Equity Ratio | 0.76 | 24.00 | Onto Innovation |
| PEG Ratio | 14.49 | 36.17 | Onto Innovation |
| EV/EBITDA | 14.55 | 32.97 | Onto Innovation |
| Profit Margin (TTM) | 21.36% | 28.46% | Nova |
| Operating Margin (TTM) | 25.04% | 30.27% | Nova |
| EBITDA Margin (TTM) | 25.04% | 30.27% | Nova |
| Return on Equity | 11.83% | 23.87% | Nova |
| Return on Assets (TTM) | 6.46% | 10.12% | Nova |
| Free Cash Flow (TTM) | $213.77M | $218.05M | Nova |
| 1-Year Return | -46.68% | 19.90% | Nova |
| Price-to-Sales Ratio (TTM) | 4.64 | 10.78 | Onto Innovation |
| Enterprise Value | $3.91B | $7.68B | Nova |
| EV/Revenue Ratio | 3.82 | 10.32 | Onto Innovation |
| Gross Profit Margin (TTM) | 53.72% | 57.32% | Nova |
| Revenue per Share (TTM) | $21 | $26 | Nova |
| Earnings per Share (Diluted) | $4.42 | $6.63 | Nova |
| Beta (Stock Volatility) | 1.44 | 1.67 | Onto Innovation |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Onto Innovation vs Nova Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Onto Innovation | 11.01% | 9.10% | -0.45% | -18.87% | -43.87% | -39.98% |
| Nova | 2.95% | 2.56% | -4.27% | 44.74% | 6.72% | 33.27% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Onto Innovation | -46.68% | 25.17% | 194.11% | 212.42% | 212.42% | 212.42% |
| Nova | 19.90% | 145.74% | 391.83% | 2,124.77% | 4,814.73% | 9,588.53% |
Performance & Financial Health Analysis: Onto Innovation vs Nova
| Metric | ONTO | NVMI |
|---|---|---|
| Market Information | ||
| Market Cap | $4.76B | $8.02B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,217,430 | 279,150 |
| 90 Day Avg. Volume | 1,133,060 | 286,683 |
| Last Close | $102.88 | $270.31 |
| 52 Week Range | $85.88 - $228.42 | $154.00 - $291.99 |
| % from 52W High | -54.96% | -7.42% |
| All-Time High | $238.93 (Jul 15, 2024) | $291.99 (Jul 07, 2025) |
| % from All-Time High | -56.94% | -7.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.51% |
| Quarterly Earnings Growth | 0.37% | 0.76% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.28% |
| Operating Margin (TTM) | 0.25% | 0.30% |
| Return on Equity (TTM) | 0.12% | 0.24% |
| Debt to Equity (MRQ) | 0.76 | 24.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $39.31 | $33.56 |
| Cash per Share (MRQ) | $17.40 | $18.52 |
| Operating Cash Flow (TTM) | $280.52M | $244.38M |
| Levered Free Cash Flow (TTM) | $185.91M | $168.62M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Onto Innovation vs Nova
| Metric | ONTO | NVMI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.99 | 41.14 |
| Forward P/E | 14.49 | 36.17 |
| PEG Ratio | 14.49 | 36.17 |
| Price to Sales (TTM) | 4.64 | 10.78 |
| Price to Book (MRQ) | 2.47 | 8.13 |
| Market Capitalization | ||
| Market Capitalization | $4.76B | $8.02B |
| Enterprise Value | $3.91B | $7.68B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.82 | 10.32 |
| Enterprise to EBITDA | 14.55 | 32.97 |
| Risk & Other Metrics | ||
| Beta | 1.44 | 1.67 |
| Book Value per Share (MRQ) | $39.31 | $33.56 |
Financial Statements Comparison: Onto Innovation vs Nova
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ONTO | NVMI |
|---|---|---|
| Revenue/Sales | $266.61M | $213.36M |
| Cost of Goods Sold | $123.37M | $91.05M |
| Gross Profit | $143.23M | $122.30M |
| Research & Development | $28.03M | $33.23M |
| Operating Income (EBIT) | $63.13M | $63.23M |
| EBITDA | $76.74M | $68.13M |
| Pre-Tax Income | $71.66M | $76.17M |
| Income Tax | $7.56M | $11.35M |
| Net Income (Profit) | $64.10M | $64.82M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ONTO | NVMI |
|---|---|---|
| Cash & Equivalents | $203.73M | $141.06M |
| Total Current Assets | $1.47B | $875.74M |
| Total Current Liabilities | $174.48M | $401.78M |
| Long-Term Debt | $8.66M | $47.66M |
| Total Shareholders Equity | $1.92B | $982.12M |
| Retained Earnings | $671.12M | N/A |
| Property, Plant & Equipment | $13.49M | $139.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ONTO | NVMI |
|---|---|---|
| Operating Cash Flow | $81.15M | $73.99M |
| Capital Expenditures | $-8.23M | $-8.86M |
| Free Cash Flow | $83.75M | $59.69M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-75.02M | $-20.00M |
Short Interest & Institutional Ownership Analysis
| Metric | ONTO | NVMI |
|---|---|---|
| Shares Short | 2.06M | 1.64M |
| Short Ratio | 1.77 | 6.28 |
| Short % of Float | 0.06% | 0.06% |
| Average Daily Volume (10 Day) | 1,217,430 | 279,150 |
| Average Daily Volume (90 Day) | 1,133,060 | 286,683 |
| Shares Outstanding | 49.24M | 29.28M |
| Float Shares | 48.52M | 29.22M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.98% | 0.77% |
Dividend Analysis & Yield Comparison: Onto Innovation vs Nova
| Metric | ONTO | NVMI |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |